182 related articles for article (PubMed ID: 11236957)
1. Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis.
Keating JT; Ince T; Crum CP
Adv Anat Pathol; 2001 Mar; 8(2):83-92. PubMed ID: 11236957
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase IX and human papillomavirus as diagnostic biomarkers of cervical dysplasia/neoplasia in women with a cytologic diagnosis of atypical glandular cells: a Gynecologic Oncology Group study in United States.
Liao SY; Rodgers WH; Kauderer J; Bonfiglio TA; Walker JL; Darcy KM; Carter R; Hatae M; Levine L; Spirtos NM; Stanbridge EJ
Int J Cancer; 2009 Nov; 125(10):2434-40. PubMed ID: 19670419
[TBL] [Abstract][Full Text] [Related]
3. MN and Ki67 (MIB-1) in uterine cervix carcinoma: novel biomarkers with divergent utility.
Costa MJ
Hum Pathol; 1996 Mar; 27(3):217-9. PubMed ID: 8600033
[No Abstract] [Full Text] [Related]
4. Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study.
Ikenberg H; Bergeron C; Schmidt D; Griesser H; Alameda F; Angeloni C; Bogers J; Dachez R; Denton K; Hariri J; Keller T; von Knebel Doeberitz M; Neumann HH; Puig-Tintore LM; Sideri M; Rehm S; Ridder R;
J Natl Cancer Inst; 2013 Oct; 105(20):1550-7. PubMed ID: 24096620
[TBL] [Abstract][Full Text] [Related]
5. Viral and histopathologic correlates of MN and MIB-1 expression in cervical intraepithelial neoplasia.
Resnick M; Lester S; Tate JE; Sheets EE; Sparks C; Crum CP
Hum Pathol; 1996 Mar; 27(3):234-9. PubMed ID: 8600036
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.
Ovestad IT; Dalen I; Hansen E; Loge JL; Dybdahl BM; Dirdal MB; Moltu P; Berland JM
Cancer Cytopathol; 2017 Apr; 125(4):283-291. PubMed ID: 27918650
[TBL] [Abstract][Full Text] [Related]
7. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia.
Keating JT; Cviko A; Riethdorf S; Riethdorf L; Quade BJ; Sun D; Duensing S; Sheets EE; Munger K; Crum CP
Am J Surg Pathol; 2001 Jul; 25(7):884-91. PubMed ID: 11420459
[TBL] [Abstract][Full Text] [Related]
8. Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial.
Wright TC; Behrens CM; Ranger-Moore J; Rehm S; Sharma A; Stoler MH; Ridder R
Gynecol Oncol; 2017 Jan; 144(1):51-56. PubMed ID: 28094038
[TBL] [Abstract][Full Text] [Related]
9. p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer.
Murphy N; Ring M; Heffron CC; King B; Killalea AG; Hughes C; Martin CM; McGuinness E; Sheils O; O'Leary JJ
J Clin Pathol; 2005 May; 58(5):525-34. PubMed ID: 15858126
[TBL] [Abstract][Full Text] [Related]
10. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
11. Utility of p16, Ki-67, and HPV test in diagnosis of cervical intraepithelial neoplasia and atrophy in women older than 50 years with 3- to 7-year follow-up.
Jackson JA; Kapur U; Erşahin Ç
Int J Surg Pathol; 2012 Apr; 20(2):146-53. PubMed ID: 22104735
[TBL] [Abstract][Full Text] [Related]
12. Dual p16 and Ki-67 Expression in Liquid-Based Cervical Cytological Samples Compared to Pap Cytology Findings, Biopsies, and HPV Testing in Cervical Cancer Screening: A Diagnostic Accuracy Study.
Prigenzi KCK; Heinke T; Salim RC; Focchi GRA
Acta Cytol; 2018; 62(2):104-114. PubMed ID: 29566392
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the sensitivity and specificity of p16/Ki-67 dual staining and HPV DNA testing of abnormal cervical cytology in the detection of histology proven cervical intraepithelial neoplasia grade 2 and above (CIN 2+).
Tay TKY; Lim KL; Hilmy MH; Thike AA; Goh ST; Song LH; Hwang JSG; Mantoo S
Malays J Pathol; 2017 Dec; 39(3):257-265. PubMed ID: 29279588
[TBL] [Abstract][Full Text] [Related]
14. [Clinical value of p16/Ki-67 immunocytochemical dual staining in cervical cancer screening].
Wang HR; Liao GD; Chen W; Qiao YL; Jiang Y
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):636-640. PubMed ID: 28835090
[No Abstract] [Full Text] [Related]
15. Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China.
Yu LL; Chen W; Lei XQ; Qin Y; Wu ZN; Pan QJ; Zhang X; Chang BF; Zhang SK; Guo HQ; Qiao YL
Oncotarget; 2016 Apr; 7(16):21181-9. PubMed ID: 27029033
[TBL] [Abstract][Full Text] [Related]
16. The association of vascular proliferation with HPV status and epithelial PCNA positivity in cervical intraepithelial lesions.
Soini Y; Pöllänen R; Kemppainen S; Pääkkö P; Lehto VP
APMIS; 1996 Mar; 104(3):183-90. PubMed ID: 8611192
[TBL] [Abstract][Full Text] [Related]
17. The significance of HPV L1 and Ki-67 detection in cervical intraepithelial neoplasm screening.
Luo Y; Cai M; Shen P; Chen H; Yao J
Minerva Med; 2019 Dec; 110(6):586-587. PubMed ID: 31295980
[No Abstract] [Full Text] [Related]
18. Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: baseline and longitudinal data.
Uijterwaal MH; Polman NJ; Witte BI; van Kemenade FJ; Rijkaart D; Berkhof J; Balfoort-van der Meij GA; Ridder R; Snijders PJ; Meijer CJ
Int J Cancer; 2015 May; 136(10):2361-8. PubMed ID: 25345358
[TBL] [Abstract][Full Text] [Related]
19. Using biomarkers as objective standards in the diagnosis of cervical biopsies.
Galgano MT; Castle PE; Atkins KA; Brix WK; Nassau SR; Stoler MH
Am J Surg Pathol; 2010 Aug; 34(8):1077-87. PubMed ID: 20661011
[TBL] [Abstract][Full Text] [Related]
20. Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature.
Yildiz IZ; Usubütün A; Firat P; Ayhan A; Küçükali T
Pathol Res Pract; 2007; 203(6):445-9. PubMed ID: 17543474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
